Promo Video
https://www.youtube.com/watch?v=CKJZUsNaHgI
A promo video about Auction4Autism.
Auction4Autism funds research into the genetic and biological causes of Autism and Medicines for Autism.With your help, our Scientists at the Ingham Institute will improve life for those with Autism.
Your personal Auction4Autism online or your direct Donation will help fund research into the Development of Medicines for Autism.
Our Basic Scientific Research is focused on finding out why
- 1 in 100 children have Autism Spectrum Disorder.
- Autism is triggered by changes to Autism genes.
- Many children with Autism often stop communicating and suffer debilitating comorbidities.
Basic Scientific Research is the foundation for understanding how the body and mind function.
Auction4Autism funds basic science research into
- Genes that cause Autism.
- Toxins that disturb Autism gene function
- Medicines that optimise Autism gene function.
Outcome
- Improved Early Diagnosis
- Improved Risk Assessment
- Improved Autism Medicines
- Improved patient selection for Clinical Trials
- Matching medicines with patient needs.
Remember: Tomorrow’s advanced medicines depend on today’s basic science.
Thanks to Basic Science, we now know many of the genes that cause Autism. Basic Science will help our Scientists discover how genes cause Autism & how to reduce their effects on patients with Autism.
RESEARCH
Auction4Autism funds research into the genetic and biological causes of Autism and Medicines for Autism. With your help, our Scientists at the Ingham Institute will improve life for those with Autism. Your personal Auction4Autism online or your direct Donation will help fund research into the Development of Medicines for Autism.
LEAD SCIENTIST
The advanced techniques and experimental models employed by Dr Clarke’s Autism Genetics Research Group at the Ingham Institute provide insight into how changes in genes and proteins increase the risk of Autism and its comorbidities and how this risk can be reversed or reduced using genetic based molecular medicines.
RECENT PUBLICATIONS
Click here to view the list of recent publications.
1. Clarke RA1,2,3*, Siddiqui KS4, Cohen-Hyams T2, Fang Z1,2, Eapen V1,2,3, Walker AK5,6, Killingsworth M7, Bridge WJ4 (2024). Immp2l regulates mitochondrial size, NAD+ biosynthesis and autistic-like behaviour. GenotypePress.com 2024.
2. Clarke RA*, Govindaraju H, Beretta M, Olzomer E, Lawther A, Walker AK, Fang Z, Eapen V, Cohen-Hyams T, Killingsworth M, Bridge WJ, Turner N, Siddiqui KS* (2024). Immp2l enhances the structure and function of mitochondrial Gpd2 dehydrogenase. International Journal of Molecular Science, 2024. Jan 12;25(2):990. doi: 10.3390/ijms25020990.